Literature DB >> 12583991

Size effect of intratracheally instilled particles on pulmonary inflammation and vascular thrombosis.

Abderrahim Nemmar1, Marc F Hoylaerts, Peter H M Hoet, Jozef Vermylen, Benoit Nemery.   

Abstract

Particulate air pollution is associated with cardiorespiratory effects and ultrafine particles (UFPs, diameter < 100 nm) are believed to play an important role. We studied the acute (1 h) effect of intratracheally instilled unmodified (60 nm), negatively charged carboxylate-modified (60 nm), or positively charged amine-modified (60 or 400 nm) polystyrene particles on bronchoalveolar lavage (BAL) indices and on peripheral thrombosis in hamster. The latter was assessed by measuring the extent of photochemically induced thrombosis in a femoral vein via transillumination. Unmodified and negative UFPs did not modify thrombosis and BAL indices. Positive UFPs increased thrombosis at 500 microg per animal (+ 341 +/- 96%) and at 50 microg per animal (+ 533 +/- 122%), but not at 5 microg per animal. Neutrophils, lactate dehydrogenase, and histamine were increased in BAL at all these doses but protein concentration was increased only at 500 microg per animal. Positive 400-nm particles (500 microg per animal) did not affect thrombosis, although they led to a neutrophil influx and an increase in BAL proteins and histamine. Using the Platelet Function Analyser (PFA-100), the platelets of hamsters were activated by the in vitro addition of positive UFPs and 400-nm particles to blood. We conclude that intratracheally administered positive ultrafine and 400-nm particles induce pulmonary inflammation within 1 h. Positive UFPs, but not the 400-nm particles enhance thrombosis. Hence, particle-induced lung inflammation and thrombogenesis can be partially uncoupled. Copyright 2003 Elsevier Science (USA)

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12583991     DOI: 10.1016/s0041-008x(02)00024-8

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  42 in total

Review 1.  Xenobiotic particle exposure and microvascular endpoints: a call to arms.

Authors:  Phoebe A Stapleton; Valerie C Minarchick; Michael McCawley; Travis L Knuckles; Timothy R Nurkiewicz
Journal:  Microcirculation       Date:  2012-02       Impact factor: 2.628

2.  Inhibition of high shear arterial thrombosis by charged nanoparticles.

Authors:  Michael T Griffin; Yuanzheng Zhu; Zixiang Liu; Cyrus K Aidun; David N Ku
Journal:  Biomicrofluidics       Date:  2018-05-29       Impact factor: 2.800

Review 3.  Do nanomedicines require novel safety assessments to ensure their safety for long-term human use?

Authors:  Peter Hoet; Barbara Legiest; Jorina Geys; Benoit Nemery
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

4.  Nanomaterial interactions with and trafficking across the lung alveolar epithelial barrier: implications for health effects of air-pollution particles.

Authors:  Nazanin R Yacobi; Farnoosh Fazllolahi; Yong Ho Kim; Arnold Sipos; Zea Borok; Kwang-Jin Kim; Edward D Crandall
Journal:  Air Qual Atmos Health       Date:  2011-03-01       Impact factor: 3.763

5.  The impracticality of biomedical rejuvenation therapies: translational and pharmacological barriers.

Authors:  Marios Kyriazis
Journal:  Rejuvenation Res       Date:  2014-08       Impact factor: 4.663

6.  A study of atherothrombotic biomarkers in welders.

Authors:  Dag G Ellingsen; Maxim Chashchin; Ingebjørg Seljeflot; Balazs Berlinger; Valery Chashchin; Leo Stockfelt; Yngvar Thomassen
Journal:  Int Arch Occup Environ Health       Date:  2019-05-21       Impact factor: 3.015

Review 7.  Direct and indirect effects of particulate matter on the cardiovascular system.

Authors:  Timothy D Nelin; Allan M Joseph; Matthew W Gorr; Loren E Wold
Journal:  Toxicol Lett       Date:  2011-11-18       Impact factor: 4.372

Review 8.  Polymeric nanoparticles in development for treatment of pulmonary infectious diseases.

Authors:  Young H Lim; Kristin M Tiemann; David A Hunstad; Mahmoud Elsabahy; Karen L Wooley
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-03-25

Review 9.  Nanotechnology: toxicologic pathology.

Authors:  Ann F Hubbs; Linda M Sargent; Dale W Porter; Tina M Sager; Bean T Chen; David G Frazer; Vincent Castranova; Krishnan Sriram; Timothy R Nurkiewicz; Steven H Reynolds; Lori A Battelli; Diane Schwegler-Berry; Walter McKinney; Kara L Fluharty; Robert R Mercer
Journal:  Toxicol Pathol       Date:  2013-02-06       Impact factor: 1.902

Review 10.  Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine.

Authors:  Xue-Qing Zhang; Xiaoyang Xu; Nicolas Bertrand; Eric Pridgen; Archana Swami; Omid C Farokhzad
Journal:  Adv Drug Deliv Rev       Date:  2012-08-17       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.